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Abstract 
Numerous transcription factors self-assemble into different order oligomeric species 
in a way that is actively regulated by the cell. Until now, no general functional role 
has been identified for this widespread process. Here we capture the effects of 
modulated self-assembly in gene expression with a novel quantitative framework. 
We show that this mechanism provides precision and flexibility, two seemingly 
antagonistic properties, to the sensing of diverse cellular signals by systems that 
share common elements present in transcription factors like p53, NF-κB, STATs, 
Oct, and RXR. Applied to the nuclear hormone receptor RXR, this framework 
accurately reproduces a broad range of classical, previously unexplained, sets of 
gene expression data and corroborates the existence of a precise functional regime 
with flexible properties that can be controlled both at a genome-wide scale and at 
the individual promoter level. 
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INTRODUCTION 
A recurrent theme in gene regulation is the self-assembly of transcription factors (TF) 
into coexisting populations of dimers, tetramers, and other higher order oligomers that 
can bind simultaneously single and multiple DNA sites. This behavior has been observed 
explicitly in the tumor suppressor p53 (1), the nuclear factor κB  (NF-κB) (2,3), the 
signal transducers and activators of transcription (STATs) (4), the octamer-binding 
proteins (Oct) (5,6), and the retinoid nuclear hormone receptor RXR (7) (Table 1). In 
these systems, the properties of self-assembly, and the partitioning into low and high 
order oligomeric species, are strongly regulated and modulated by several types of 
signals, such as ligand binding (8), protein binding (9,10), acetylation (11), and 
phosphorylation (6,12). The general implications of this modulation, however, are not 
clear. 
 At the level of single DNA sites, it is well established that the effects of TF are 
finely determined by their concentration and cognate DNA sequences (13). Processes 
based on interactions with different molecules and post-transcriptional modifications are 
assumed to affect mainly the DNA binding properties of the TFs or their ability to recruit 
coregulators. This idea is entrenched in the field of gene regulation and is systematically 
used as a guiding principle in the ongoing development of molecular therapies against 
diverse diseases (14). But TFs rarely act through just a single binding site (6,15-21) 
(Table 1). Modulated self-assembly (MSA) provides a key mechanism for controlling the 
ability of TFs to bind two or more DNA sites simultaneously.  
 To determine the common wide-ranging effects of MSA, we have developed a 
general quantitative framework that accurately links MSA with control of gene 
expression (Figure 1). It focuses on the general aspects of the core control mechanism 
shared by the wide variety of regulatory systems where MSA is present, which include 
TF self-assembly and its modulation, binding of the TF oligomers to DNA, and the 
resulting transcriptional responses. This quantitative framework allowed us to uncover 
modulation of the oligomeric states of TFs as a flexible mechanism for precise sensing of 
molecular signals in the presence of intracellular fluctuations. Precision ensures that the 
transcriptional response is consistently triggered at a given modulator signal strength 
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irrespective of the TF concentration. Flexibility allows the precise triggering point to be 
changed, up to several orders of magnitude, both at the individual promoter level by 
changing its DNA sequence and at a genome-wide scale by changing the molecular self-
assembly properties.  
 This methodology identified a core set of features needed to implement control of 
transcription by MSA that are present in a wide variety of structurally different systems 
(Table 1). As an exemplar of these systems, we have considered explicitly the nuclear 
hormone receptor RXR. In this case, the quantitative framework accurately reproduced, 
in some instances even without free parameters, a broad range of classical, previously 
unexplained gene expression experimental data and demonstrated how flexible precise 
control of gene expression can be achieved directly at the molecular level through 
modulation of the oligomerization state of transcriptional regulators. 
 
MATHERIALS AND METHODS 
The first step in the signaling cascade orchestrated by MSA is the regulation of the 
relative abundance of the oligomerization states of the TF (Figure 1). The self-assembly 
modulator, such as a ligand that binds to a TF or a kinase that phosphorylates the TF, 
affects the low-order oligomers to promote or prevent their self-assembly. We consider 
explicitly tetramers, 4n , dimers, 2n , and non-tetramerizing dimers, 
*
2n , as relevant high 
and low order oligomeric species. Other oligomerization pairs, such as octamer-tetramers 
or dimer-monomers, are mathematically equivalent to tetramer-dimers.  
 We quantitate the effects of self-assembly modulation through the modulator 
function *2 2([ ]) [ ] / [ ]f s n n= , which describes, in terms of concentrations, the partitioning 
into the tetramerizing and non-tetramerizing dimers by the self-assembly modulator, s . 
This process affects dimer and tetramer concentrations, which are related to each other 
through 22 4 td[ ] / [ ]n n K= , where tdK  is the tetramer-dimer dissociation constant. 
 The precise form of the modulator function is given by the specific mode of 
action of the modulator. An explicit example is lig([ ]) [ ] /=f s s K  for a ligand s  that upon 
binding to the dimer 2n , with dissociation constant ligK , renders it unable to tetramerize 
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in the form *2n . Another relevant, mechanistically different situation corresponds to 
([ ]) / ([ ] )dephos phosf s k s v=  for phosphorylation in the linear regime of the non-
tetramerizing, *2n , into the tetramerizing, 2n , dimer species. In this case, [ ]s  is the 
concentration of active kinases and phosv  and dephosk  are the phosphorylation and 
dephosphorylation rate constants, respectively.  In general, several mechanisms can be 
involved at the same time in controlling the oligomerization properties. For instance, the 
case in which the two previous processes are combined so that the dimer has to be both 
free of ligand and phosphorylated to be able to tetramerize leads to a two-variable 
modulator function given by 
lig lig([ ],[ ]) [ ] / [ ] / ( [ ] ) / ([ ] )= + +l p l l dephos p phos dephos p phosf s s s K s k K s v k s v , where [ ]ls  is the 
ligand concentration and [ ]ps  is the concentration of active kinases. 
 Binding of the different TF oligomers to the DNA sites mediates the 
transcriptional effects of the self-assembly modulator (Figure 1). Typically, tetramers and 
both types of dimers bind single DNA sites in a very similar way, with free energies os1GΔ  
and os2GΔ , for site 1 and 2, respectively. These quantities are related to the corresponding 
dissociation constants through os1 1ln( )sG RT KΔ =  and os2 2ln( )sG RT KΔ = .  Tetramers, in 
addition, can bind two sites simultaneously because they have two DNA binding 
domains, one from each of its two constituent dimers, which contribute with os1GΔ  and 
o
s2GΔ  to the free energy. The simultaneous binding of two domains is typically 
accompanied by conformational changes, e.g. twisting and bending, in both the tetramer 
and DNA (22,23), which contributes with an additional conformational term, oCGΔ , to the 
free energy. Therefore, the standard free energy of the state with the tetramer bound to 
two sites is given by o o os1 s2 CG G GΔ +Δ + Δ . This conformational contribution has been 
studied in detail in the case of DNA looping by prokaryotic TFs and is dependent, among 
others, on the TF and DNA flexibility, the relative position of the DNA binding sites, and 
the DNA supercoiling state (22,23). 
 We use statistical thermodynamics to quantitatively describe binding to DNA in 
terms of free energies and concentrations of the different oligomeric species (24-26). The 
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key quantity is the statistical weight, or Boltzmann factor, defined as 
o /*
4 2 2[ ] [ ] [ ]i i i i
t d m G RT
iZ n n n e
−Δ= , which relates the relative probability of the binding state i  
with its standard free energy oiGΔ . The exponents it , id , and im  correspond to the 
number of tetramers, dimers, and non-tetramerizing dimers in the state i , respectively. 
The factor RT  is the gas constant, R , times the absolute temperature, T . The probability 
of a given group of binding states c , ∈=∑ ∑c i ii c iP Z Z , is obtained by adding the 
statistical weights of its states and normalizing by the sum for all the possible states. 
  For a system with two binding sites, there are 17 binding states (Figure 1). These 
states are those with both sites empty; one occupied by a dimer or a tetramer; two sites 
occupied by two dimers, by two tetramers, or a dimer and tetramer; and two sites 
occupied simultaneously by a single tetramer. In the case of states with dimers, one has to 
take into account that a dimer can either be in the form that allows or prevents 
tetramerization. In general, each binding state includes a constellation of molecular 
substates with different DNA conformations. For instance, the state with both sites empty 
can include a bent DNA conformation, as in the case when the two sites are occupied 
simultaneously by a single tetramer, but the lack of a tetramer to stabilize the 
conformation makes this conformation highly unlikely. This type of effects has been 
described in detail for other TF that bind two DNA sites simultaneously, such as the lac 
repressor (27).    
 There is also the possibility that oligomerization is so weak in solution that it is 
only observed on DNA. This effect can be put in quantitative terms with our framework 
by considering that the state with the tetramer bound simultaneously to two DNA sites 
(Figure 1) can also be described as two interacting dimers that bind cooperatively to 
DNA. The statistical weight of this state is given by 
o o o
s1 s2 C( )/
2 4[ ]
− Δ +Δ +Δ= G G G RTZ n e  in terms of 
tetramer concentration and by 
o o o
s1 s2 C( )/2
2 2 td([ ] / )
− Δ +Δ +Δ= G G G RTZ n K e  in terms of dimer 
concentration, which can be rewritten as 
o o
s1 s2 int( )/2
2 2[ ]
− Δ +Δ +Δ= G G G RTZ n e  with 
o
int C tdlnΔ = Δ +G G RT K . Thus, a very high dissociation constant that does not lead to 
significant tetramerization in solution is sufficient to promote tetramerization on DNA 
when the conformational free energy is sufficiently low. Intuitively, tetramerization is 
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observed on DNA because binding to DNA brings the tetramerization domains close to 
each other and increases their local concentration. 
 Two differentiated types of transcriptional responses can be constructed from the 
binding states of the TF on DNA (Figure 1).  
 The first type, referred to as response R1, involves a high order oligomer that 
simultaneously binds two non-adjacent DNA sites. Upon binding, the high-order 
oligomer loops out the intervening DNA and positions a distal enhancer in the vicinity of 
the promoter region to control transcription. The probability tP  of the state with the 
tetramer bound to the two DNA sites simultaneously (Table 2) determines the effective 
transcription rate through the expression R1 ref t t t(1 )P PΓ = Γ − +Γ , which weights the 
transcription rates that the system has with, tΓ , and without, refΓ , the distal enhancer 
close to the promoter.  
 The second type, denoted here response R2, takes advantage of the differentiated 
recruitment abilities of different oligomerization states. This mode of regulation applies 
to a coactivator that is recruited by a low-order oligomer by binding to a molecular 
surface that is occluded in the high-order oligomer. In this case, the effective 
transcription rate is given by R2 ref do od dd do do od od dd dd(1 )Γ = Γ − − − +Γ +Γ +ΓP P P P P P . The 
subscripts do, od, and dd of the transcription rates Γ  and probabilities P  refer to the 
group of states with dimers bound to just site 1, to just site 2, and to both sites, 
respectively (Table 2). refΓ  is the transcription rate with no dimers bound, including 
empty sites and sites occupied by tetramers.  
 Responses R1 and R2 embrace the prototypical cases mediated by long and short 
range interactions between regulatory elements. They are controlled by the relative 
occupancy of DNA binding sites by the different oligomeric species. This mode of 
functioning differs from other systems with multiple binding sites, like the lac operon, 
which are controlled by the absolute occupancy of their sites by a single oligomeric 
species (28). For instance, IPTG, an inducer of the lac operon, does not affect the 
oligomerization state of the tetrameric lac repressor but prevents each of its two DNA 
binding domains from significantly binding their cognate sites (28,29).  
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RESULTS 
To uncover the unique characteristics that emerge from the core structure of MSA in such 
a general wide variety of structurally different systems (Table 1), we focus on a 
functional regime that guarantees that there is response to changes in the self-assembly 
modulator concentration. This regime considers two properties. The first one is that the 
TF concentration is sufficiently high for it to significantly bind DNA. In mathematical 
terms, it implies 
o
s1 /*
4 2 2[ ] [ ] [ ]
Δ+ + >> G RTn n n e  and os2 /*4 2 2[ ] [ ] [ ] Δ+ + >> G RTn n n e . The second 
one is that the tetramer concentration is sufficiently low, *4 2 2[ ] [ ] [ ]<< +n n n , so that they 
do not to take completely over the binding. The reason is that for typical values of oCGΔ , 
tetramers bind more strongly to two DNA sites simultaneously than dimers do to a single 
DNA site (27,30,31).  
 The key implication of this regime is that the probabilities of the different groups 
of binding states simplify in such a way (see Table 2) that the transcriptional responses 
are governed by the reduced expressions 
 R1 ref t t t
R2 ref t dd t
(1 )
(1 )
P P
P P
Γ = Γ − +Γ
Γ ≈ Γ +Γ −   (1) 
with 
 ( ) oCt 2 / td
1
1 1 ([ ]) G RT
P
f s e KΔ
≈ + + , (2) 
which show that responses R1 and R2, despite being mechanistically different, follow the 
same control logics. In both cases, the two-site binding of the tetramer, quantified by tP , 
determines the contributions of the reference and activated transcriptional states. The end 
result is even more remarkable because the particular form of tP  imparts precision and 
flexibility to the transcriptional responses, two properties that are the cornerstone of 
natural gene expression systems but that have proved to be highly elusive because of their 
seemingly antagonistic character (13). 
 Precision ensures that the transcriptional response is consistently triggered at a 
given modulator signal strength irrespective of the particular TF concentration, which 
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cancels out in the reduced equations that govern the system behavior. Flexibility, on the 
other hand, allows the precise triggering point to be altered, up to several orders of 
magnitude, both at the individual promoter level by changing its organization — oCGΔ  
depends on the distance between the two DNA binding sites (17,22)— and at a genome-
wide scale by changing the molecular self-assembly properties — ([ ])f s  and tdK  affect 
the regulation of all genes in the same way.  
 All these results can be observed explicitly in the retinoid X receptor (RXR), an 
exemplar of the essential regulators that share the central features of MSA (Table 1).  
RXR controls a large number of genes by binding to DNA as homodimer, homotetramer, 
or obligatory heterodimerization partner for other nuclear receptors. Nuclear retinoid 
receptors are highly significant because they mediate the pleiotropic effects of retinoic 
acid, which include cell proliferation, differentiation, and embryonic development and 
affect the carcinogenic process in a number of organs (32). 
 The canonical self-assembly modulator of RXR is the hormone 9-cis-retinoic acid 
(9cRA), a derivative of Vitamin A, which binds each RXR subunit independently of its 
oligomerization state (33) and prevents dimers with their two subunits occupied from 
tetramerazing (8). This behavior is consistent with 2n  being an apo-dimer and with 
*
2n  
being a holo-dimer, as observed in the respective crystal structures of the dimers with no 
ligand bound (34) and with two ligands bound (35). The crystal structure of one tetramer 
with two ligands bound (36) shows that two dimers with just one ligand each can form 
tetramers with a structure similar to those of two apo-dimers. In addition to 9cRA, there 
are other ligands of RXR, as for instance, the oleic acid, docosahexaenoic acid, 
methoprene acid, and phytanic acid (35).  
 These early steps in sensing 9cRA and other ligand concentrations are taken into 
account by the explicit form of the modulator function, which we obtain from the mass 
action law as  
 
* 2
2
2
2 lig lig
[ ] [ ]([ ])
[ ] 2 [ ]
n sf s
n K K s
= = + ,  (3) 
where ligK  and [ ]s  are the ligand-RXR dissociation constant and the ligand 
concentration, respectively (see Supplementary Methods).  
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 To compare with the experimental data, we normalize the fold induction, a 
measure of relative changes in transcriptional activity, so that its variation ranges from 0 
to 1. This quantity, referred to as normalized fold induction (NFI), is defined explicitly as 
( ) ( )max1 / 1= − −NFI FI FI , where maxFI  is maximum value of the fold induction FI .  In 
terms of the NFI, the results do not depend on parameters related to the baseline and 
maximum expression levels and it becomes possible to effectively compare experiments 
on different promoters and cell lines (see Supplementary Methods). The only parameters 
needed to characterize the shape of the response in the functional regime are ligK  and 
tdK , which have been measured experimentally, and 
o
CGΔ , which can be inferred by 
adjusting its value to reproduce the experimental data. 
 This approach accurately describes the experimental observations (16) for the 
ligand 9cRA and a promoter with two non-adjacent DNA binding sites for RXR and a 
distal enhancer (Figure 2A). Simultaneous binding of an RXR tetramer to the two sites 
loops out the intervening DNA and brings the enhancer close to the promoter region 
(response R1). Increasing the concentration of 9cRA prevents the formation of RXR 
tetramers and leads to deactivation of transcription.  
 The very same approach also captures in detail the observed behavior when the 
two DNA binding sites are next to each other, as in the classic set of experiments that 
uncovered 9cRA as the cognate ligand of RXR, for different promoters and cell lines 
(Figure 2B). In these cases, only the dimeric forms of RXR with ligand bound can recruit 
a coactivator (response R2) and increasing the concentration of 9cRA results in the 
activation of transcription. The extent of activation is modulated by the RXR AF-1 
domain and RXR phosphorylation (37-39).  
 This framework has the much-sought ability to fully predict, without free 
parameters, the responses to different ligands from the values of oCGΔ  obtained in 
response to just a single ligand. Applied to the all-trans retinoic acid (atRA), which was 
tested early on as a potential cognate ligand of RXR (40,41), the approach closely 
recapitulates its effects on transcription for different cell types and promoters from the 
values of oCGΔ  inferred in the responses to 9cRA (Figure 2C). This ability to fully predict 
responses without free parameters is especially important because it provides a direct 
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avenue to transfer specific molecular information of the ligand-TF interaction, as 
described by the measured or computed parameters, across scales up to the transcriptional 
effects.  
 The high variability of the transcriptional responses, as observed in Figure 2, has 
been a long-standing recurrent issue in RXR gene regulation. In particular, the half-
maximum response point, characterized by the EC50, ranges from just above the RXR-
ligand dissociation constant up to values 30-fold higher (Table 3). Our results have 
identified MSA as a potential mechanism to control the EC50 at the single-gene level 
through the value of oCGΔ  (Table 3). This promoter-dependent flexibility indicates that 
for these systems, the observed variability is not a random aspect of the experimental 
setup but the result of RXR precisely tailoring the response to each individual gene. 
 The observed variability can be collapsed in the form of response landscapes 
(Figure 3), which represent the transcriptional activity as a function of the conformational 
free energy in addition to just the usual ligand concentration of dose-response curves. The 
landscapes explicitly show the ability of RXR to shape the molecular response to ligand 
binding in a promoter-dependent way. The response landscapes show how the EC50 
increases as the conformational free energy decreases in a way that closely matches the 
experimental observations (Figure 3). 
 To investigate the extent to which typical experimental conditions fall within the 
functional regime (which, as previously described, is characterized by 
o
s1 /*
4 2 2[ ] [ ] [ ]
Δ+ + >> G RTn n n e , os2 /*4 2 2[ ] [ ] [ ] Δ+ + >> G RTn n n e , and *4 2 2[ ] [ ] [ ]<< +n n n ), we 
considered the model for RXR in the whole-parameter space. All groups of binding states 
were considered explicitly without simplifications of the expressions for the 
corresponding probabilities (Table 2). In addition to the relevant quantities of the 
functional regime, the whole-parameter space includes the experimentally measured free 
energies of binding to DNA, the RXR dimer-monomer dissociation constant, and the 
nuclear RXR concentration. The results (Figure 4) are virtually independent of the 
precise value of the total nuclear RXR protein concentration over, at least, a 10-fold 
range and accurately capture the diverse dose-response curves observed in the 
experiments, in agreement with the results for the functional regime. In all cases, the 
ranges of concentrations include 550 nM, the estimated RXR nuclear concentration in 
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HL-60 cells (7). Therefore, the ability to elicit flexible and precise responses, as 
uncovered in the general analysis, is also present when the particularities of RXR-
mediated transcriptional responses are taken into account. 
 
DISCUSSION 
Cellular processes rely on intricate molecular mechanisms to function in extraordinarily 
diverse intra- and extra-cellular environments. Eukaryotic gene expression, in particular, 
has shown to be exceedingly complex (42-44). Just the core of the transcriptional 
machinery itself involves a wide variety of components with oscillatory patterns of 
macromolecular assembly and phosphorylation (45). On top of the constitutive processes, 
there are many other molecular interactions that provide regulation, enhancing or 
reducing gene expression and adjusting to changing cellular conditions (46). To 
understand how these different levels of molecular complexity contribute to the observed 
behavior, one needs the right approaches (47,48).  
 The quantitative framework we have developed provides an efficient avenue to 
connect the molecular properties of MSA with its effects in the control of gene 
expression. This framework allowed us to uncover unique properties of control of gene 
expression by MSA that lead to a flexible mechanism for precise sensing of diverse types 
of self-assembly modulation signals, irrespective of changes in transcription factor 
concentration. Application of this methodology to the nuclear hormone receptor RXR 
accurately describes the experimentally observed transcriptional responses for both 
enhancers (response R1) and coactivators (response R2) from just the molecular 
properties of the components (Figures 2A and 2B), and successfully predicts the observed 
behavior without free parameters (Figure 2C). A detailed analysis of the whole-parameter 
space reveals that regulation by RXR is functioning in a precise regime, with minimal 
dependence on RXR nuclear concentration (Figure 4), in which the responses are highly 
diverse as a result of the inherent flexibility that accompanies precision in the control of 
gene expression by MSA (Figure 3). 
 The observed TF-concentration insensitivity of control of gene expression by 
MSA contrasts with the traditional role of RXR as obligatory heterodimerization partner 
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for other nuclear receptors, which relies on the absolute occupancy of the cognate binding 
sites by the heterodimer. In the case of RXRα:PPARγ regulation of adipogenesis, 
however, it has been observed that several promoters are controlled rather by the relative 
occupancy between RXRα:PPARγ heterodimers and other RXRα heterodimers or homo-
oligomers (49). Our framework provides a starting point to consider these more complex 
situations by coupling MSA with hetero-oligomerization and to combine these extensions 
with recent bioinformatics methods (50,51) to make accurate predictions on gene 
expression based on the binding profiles observed in the experimental data (49). 
 The combined presence of flexibility and precision in the control of gene 
expression by MSA, as explicitly shown for RXR, allows a single TF to simultaneously 
regulate multiple genes with promoter-tailored dose-response curves that consistently 
maintain their diverse shapes for a broad range of the TF concentration changes. These 
features are especially important because essential TFs like p53, NF-κB, STATs, Oct, 
and RXR, each of which have all the core elements that form the backbone of control of 
gene expression by MSA, regulate multiple genes that engage in processes as diverse as 
cancer, inflammation, autoimmune diseases, and cellular differentiation. These results 
indicate that the prospects for devising more effective molecular therapies for systems 
controlled by MSA will greatly benefit from shifting potential intervention points from 
those that affect absolute concentrations and single-site binding to those that can tackle 
concentration ratios and promoter properties. 
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TABLES 
Table 1. Modulated self-assembly of transcription factors 
 
TFa Self-assembly modulation Oligomerization statesb DNA binding  
RXR  ligand-binding (8) monomer, dimer*, tetramer* 
(7) 
1 site, 4 consecutive half-sites 
(15), 2 separated sites (16) 
p53 protein-binding (9,10), 
acetylation (11) 
monomer, dimer, tetramer*, 
stacked-tetramers* (1) 
1 site, 2 separated half-sites, 2 
separated sites (17,18) 
NF-κB protein-mediated dimer*, tetramer* (2,3) 2 separated sites (19) 
STAT phosphorylation (12) dimer*, tetramer* (4) tandem sites (20,21) 
Oct phosphorylation (6) monomer*, dimer* (5), 
tetramer* (6) 
1 site, 2 separated sites (6) 
 
aFor each transcription factor (TF), the table shows the experimentally observed 
mechanism of the self-assembly modulation process, the oligomerization states involved, 
and the corresponding arrangement of DNA binding sites at the promoter.  
bThe symbol * indicates the oligomeric species that have been observed to substantially 
bind DNA.
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Table 2. Probability, cP , of the different groups of binding states 
 
cP  Statesa Full expressionb 
Simplified  
expressionc 
tP  2 ( ) ( )
o
C
o o o
C s1 s2
/
4
/ / /* *
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aStates involved in the group as described in Figure 1. 
bThe expressions for the probabilities follow from the statistical thermodynamic approach 
with the free energies of each state as described in Figure 1. 
cSimplified expressions for the probabilities in the functional regime. 
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Table 3. EC50 control by ligand binding strength and conformational free energy 
 
EC50  
(nM) Ligand 
ligK  
(nM) 
o
CGΔ  
(kcal/mol)
287.4 9cRA 8 8.03
77.8 9cRA 8 9.47
18.3 9cRA 8 10.76
14.3 9cRA 8 10.92
3403.2 atRA 350 9.47
798.7 atRA 350 10.76
626.0 atRA 350 10.92
 
The EC50 is defined as the ligand concentration that gives the half-maximum response. 
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FIGURE LEGENDS 
Figure 1. Quantitative modeling of control of gene expression by modulated self-
assembly. Intracellular signals are processed through modulated self-assembly into 
populations of different oligomeric species that upon DNA binding engage in 
transcription control. Modulated self-assembly.— The intensity of a self-assembly 
modulator signal [ ]s , e.g. ligand or active kinase concentration, regulates the formation 
of high order oligomers  by modifying (represented as a yellow spark) the low order 
oligomers and preventing their self-assembly into the high order species.  DNA 
binding.— The oligomeric species bound to DNA (in orange/red) are described by their 
free energies with the statistical weights ( stateZ ) shown for each binding state (expression 
in black). The parenthesized number, in blue, labels each of the 17 states and the 
molecular representations illustrate the binding combinations of the transcriptional 
regulator to the two DNA sites (site 1 and site 2). The top left box summarizes the 
notation. Transcriptional control.— One state (state 2) can trigger response R1, in which 
an enhancer is positioned in the vicinity of the promoter region, and twelve states (states 
6-17) can potentially trigger response R2, in which a coactivator is recruited to the 
promoter region. Dimers and tetramers have been drawn as compositions of the nuclear 
hormone receptor RXR structures from the PDB files 1BY4 (DNA binding domains 
bound to the two half-sites on DNA, or RXR response elements) and 1G1U (ligand 
binding domains). 
 
 
Figure 2.  Prediction of RXR-mediated transcriptional responses to 9cRA and atRA 
ligands. The results of the model (lines) for the functional regime are compared to the 
normalized fold induction (NFI) from experimental data (symbols) for different 
promoters and ligands. The model uses the experimental values lig 8 nMK =  for 9cRA 
(52) or lig 350 nMK =  for atRA (53), and td 4.4 nMK =  (7). The conformational free 
energy oCGΔ  (shown in kcal/mol) is inferred from just the experimental data for 9cRA by 
minimizing the mean squared error between model and experiments and the resulting 
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value is used subsequently for responses to atRA. (A) Response to 9cRA for a system 
with two separated DNA binding sites for RXR and a distal enhancer. Experimental gene 
expression data is taken from Figure 5b of Yasmin et al. (16), which used COS-7 cells 
transfected with the reporter, consisting of double RXRE and a UAS site 300 bp 
upstream, in a vector encoding GAL4-VP16.   The NFI was computed as R1 tNFI P=  (see 
Supplementary Methods) with equations (2) and (3). In this case, the half-maximum 
response concentration, or EC50, is about 35 times higher than the 9cRA-RXR 
dissociation constant.  (B) Responses to 9cRA for systems with contiguous DNA binding 
sites for RXR. The variability of the dose-response curves, including 10-fold changes in 
the EC50 and different slopes, is accurately captured by the model by just adjusting oCGΔ . 
The three different curves correspond to three different experimental systems, reported in 
Figure 5a of Heyman et al. (40) (top), which used S2 cells cotransfected with the 
expression plasmid A5C-hRXRα and the reporter plasmid ADH-CRBPII-LUC; Figure 4b 
of Levin et al. (41) (center), which used CV-1 cells cotransfected with the reporter 
CRBPII-RXRE-CAT construct and plasmid RXRα; and Figure 5b of Heyman et al. (40) 
(bottom), which used CV-1 cells cotransfected with the expression plasmid pRSh-RXRα 
and the reporter plasmid TK-CRBPII-LUC. The NFI was computed as 
( )4R2 lig t1 (1 [ ] / ) (1 )−= − + −NFI s K P  (see Supplementary Methods) with equations (2) and 
(3). (C) Responses to atRA for systems with contiguous DNA binding sites for RXR. The 
three different dose-response curves correspond to the three systems of Figure 2B with 
the all-trans retinoic acid (atRA) as ligand of RXR instead of 9cRA. The highly variable 
dose-response curves are fully predicted without free parameters using the values of oCGΔ  
inferred in Figure 2B.  
 
Figure 3.  Local and global flexibility in the response landscapes. The normalized fold 
induction (NFI) for RXR from the model, computed as in Figure 2, is shown as a function 
of both the self-assembly modulator intensity (either 9cRA or atRA concentration) and 
the conformational free energy oCGΔ . The figures on the bottom are density-plot 
projections of the corresponding NFI on the top, with dark and light gray corresponding 
to low and high values of the NFI, respectively. The red line corresponds to NFI =0.5 and 
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shows the dependence of the half-maximum response concentration, or EC50, with the 
conformational free energy. The EC50 can be changed locally, at the single-promoter 
level, by changing the value of oCGΔ , or globally, at a genome-wide scale by changing 
ligK , the strength of the ligand binding to RXR. The 3D plots show the same 
experimental data (symbols) as in (A) Figure 2A, (B) Figure 2B, and (C) Figure 2C along 
with the dose-response curves (black lines) for the corresponding values of the 
conformational free energy.  The values of the parameters used are td 4.4 nM=K  (7) and 
either  lig 8 nM=K  for 9cRA (52) or lig 350 nM=K  for atRA (53).  
 
Figure 4. Precision and flexibility of the transcriptional responses. The model for the 
whole-parameter space (see Supplementary Methods) reproduces the different dose-
response curves regardless of 10-fold changes in total RXR concentration. The 
normalized fold induction from experimental data (symbols) and the model (lines) is 
shown for the same systems as in (A) Figure 2A, (B) Figure 2B, and (C) Figure 2C. The 
results agree with the experimental data over 10-fold changes of the total RXR 
concentration, given by *T 4 2 2 14[ ] 2[ ] 2[ ] [ ]= + + +n n n n n , which confirms the presence of a 
precise functional regime for typical molecular parameters.  The experimental values 
used are lig 8 nMK =  for 9cRA (52) or lig 350 nMK =  for atRA (53); td 4.4 nMK =  and 
dm 155 nMK =  (7). The free energies of binding are obtained through their corresponding 
dissociation constants as os1 1ln( )sG RT KΔ =  and os2 2ln( )sG RT KΔ =  with 
s2 s1 8.8 nMK K= =  (54). dmK , s1K , and s2K  are the dimer-monomer, RXR-site 1, and 
RXR-site 2 dissociation constants, respectively. The values of the conformational free 
energies were inferred in Figure 2. The 10-fold range of total RXR concentration was 
chosen for each specific system so that it best reproduces the experimental data in Figures 
4A and 4B. The explicit value of Tn  is shown on the top of each graph (in nM units). The 
results of Figure 4C are predictions without free parameters.    
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SUPPLEMENTARY METHODS 
 
Normalized fold induction for response R1 
In the case of an enhancer being brought to the promoter, the fold induction and 
maximum fold induction are R1 ref/FI = Γ Γ  and max t ref1 ( / )FI = + Γ Γ , respectively, 
which lead to a normalized fold induction given by 
 R1 tNFI P= .  
Therefore, in the case of response R1, the normalized fold induction is determined by just 
the probability of the conformation with the tetramer bound to the two DNA sites. 
 
Normalized fold induction for response R2 
The case of a coactivator being recruited by an active RXR dimer is more involved 
because the self-assembly modulator, 9cRA, is also an agonist of RXR. The reason is that 
an RXR dimer has to bind at least one 9cRA molecule to recruit a coactivator. Therefore, 
the quantities Γc  (see text) are themselves effective transcription rates given by 
ref no ligand act no ligand(1 )Γ = Γ +Γ −c P P , where no ligandP  is the probability that none of the 
dimers of the group of binding states c  has a ligand bound. It is given by 
2
no ligand 1/ (1 [ ] / )= + ligP s K  for the groups of binding states with one dimer (od and do) and 
by 4no ligand 1/ (1 [ ] / )= + ligP s K  for the group of binding states with the two dimers (dd). 
The resulting effective transcription rates for the groups of binding states with dimers —
( )2od ref act ref( ) 1 (1 [ ] / )−Γ = Γ + Γ −Γ − + ligs K , ( )2do ref act ref( ) 1 (1 [ ] / )−Γ = Γ + Γ −Γ − + ligs K , 
 2
and ( )4dd ref act ref( ) 1 (1 [ ] / )−Γ = Γ + Γ −Γ − + ligs K — depend explicitly on the self-assembly 
modulator concentration and take into account that binding of at least one ligand to RXR 
activates the dimeric form in addition to modulating the oligomerization state.  In the 
case of response R2, therefore, we have R2 ref/FI = Γ Γ  and max act ref1 ( / )FI = + Γ Γ  and the 
resulting normalized fold induction is given by  
 ( ) ( )2 4R2 lig od do lig dd1 (1 [ ] / ) ( ) 1 (1 [ ] / )− −= − + + + − +NFI s K P P s K P  
for the whole-parameter space, and by 
 ( )4R2 lig t1 (1 [ ] / ) (1 )−≈ − + −NFI s K P  
in the functional regime. 
 
Modulator function for RXR 
The self-assembly modulator of RXR is the hormone 9-cis-retinoic acid  (9cRA), a 
derivative of Vitamin A, which binds each RXR molecule independently of its 
oligomerization state and prevents dimers with their two subunits occupied from 
tetramerazing. Therefore, there are several types of tetramerizing dimers. We use the 
notation 0,0[ ]n  for the dimer concentration with no hormone bound; 0,1[ ]n  and 1,0[ ]n  for 
those with just one 9cRA molecule bound; and 1,1[ ]n  for those with two 9cRA molecules 
bound. Binding of 9cRA to RXR follows the usual mass action law: 1,0 0,0 lig[ ] [ ][ ] /n n s K= , 
0,1 0,0 lig[ ] [ ][ ] /n n s K= , and 2 21,1 0,0 lig[ ] [ ][ ] /n n s K= , where ligK  is the ligand-RXR 
dissociation constant. The concentrations of tetramerazing and non-tetramerazing dimers 
are therefore related to each other by 
 3
 2 1,0 0,1 0,0 0,0 lig[ ] [ ] [ ] [ ] [ ](2[ ] / 1)n n n n n s K= + + = +  
 * 2 22 1,1 0,0 lig[ ] [ ] [ ][ ] /n n n s K= =  
from which we obtain the explicit form of the modulator function:  
 
* 2
2
2
2 lig lig
[ ] [ ]([ ])
[ ] 2 [ ]
n sf s
n K K s
= = + .  
This expression explicitly indicates how the ligand controls the relative concentrations of 
the different oligomerization states that shape the transcriptional response. 
 
Computational approach for RXR in the whole-parameter space 
The whole-parameter space needs to consider explicitly the total nuclear RXR 
concentration, *T 4 2 2 14[ ] 2[ ] 2[ ] [ ]= + + +n n n n n , which includes the contributions from 
monomer concentration 1[ ]n  in addition to those from the tetramer, dimer, and non-
tetramerizing dimer. Dimerization is described by ( )2 *1 2 2 dm[ ] / [ ] [ ]+ =n n n K , where dmK  is 
dimer-monomer dissociation constant. For given values of the parameters, the 
concentrations of the four oligomerization states are obtained by solving numerically the 
equations for the total nuclear RXR concentration, dimerization, tetramerization, and 
modulator function for each ligand concentration. The resulting oligomeric 
concentrations are used to obtain the corresponding probabilities (Table 2), which in turn 
are substituted in the expressions R1 tNFI P=  and 
( ) ( )2 4R2 lig od do lig dd1 (1 [ ] / ) ( ) 1 (1 [ ] / )− −= − + + + − +NFI s K P P s K P  to obtain the normalized 
fold induction for responses R1 and R2, respectively. 
